Hims & Hers Health (HIMS)

Hims & Hers Health Stock Analysis & Ratings

HIMS Stock Chart & Stats

Day’s Range$3.35 - $3.54
52-Week Range$2.72 - $15.55
Previous Close$3.41
Average Volume (3M)2.35M
Market Cap$731.52M
P/E Ratio-9.4
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-0.36



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $2.72 and its highest was $15.55 in the past 12 months.
    What is Hims & Hers Health’s market cap?
    Hims & Hers Health’s market cap is $731.52M.
      What is Hims & Hers Health’s price target?
      The average price target for Hims & Hers Health is $7.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $10.00 ,the lowest forecast is $6.00. The average price target represents 119.72% Increase from the current price of $3.55.
        What do analysts say about Hims & Hers Health?
        Hims & Hers Health’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Hims & Hers Health’s upcoming earnings report date?
          Hims & Hers Health’s upcoming earnings report date is Aug 10, 2022 which is in 82 days.
            How were Hims & Hers Health’s earnings last quarter?
            Hims & Hers Health released its earnings results on May 09, 2022. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.083 by $0.003.
              Is Hims & Hers Health overvalued?
              According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
                Does Hims & Hers Health pay dividends?
                Hims & Hers Health does not currently pay dividends.
                What is Hims & Hers Health’s EPS estimate?
                Hims & Hers Health’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Hims & Hers Health have?
                Hims & Hers Health has 206,060,000 shares outstanding.
                  What happened to Hims & Hers Health’s price movement after its last earnings report?
                  Hims & Hers Health reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.083. Following the earnings report the stock price went down -6.469%.
                    Which hedge fund is a major shareholder of Hims & Hers Health?
                    Among the largest hedge funds holding Hims & Hers Health’s share is Royce & Associates LLC. It holds Hims & Hers Health’s shares valued at 1M.


                      Hims & Hers Health Stock Analysis

                      Smart Score
                      Price Target
                      ▲(119.72% Upside)
                      Strong Buy
                      The Hims & Hers Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Hims & Hers Health

                      Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.

                      Similar Stocks
                      Price & Change
                      Finance of America Companies
                      Desktop Metal
                      ChargePoint Holdings

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis